Tawny Hammett-Irvine is the Founder and Chief Executive Officer of MOSONA Inc., where she is pioneering the frontier of biological intelligence, integrating quantum biology, bioelectricity, and advanced AI to redefine human health, performance, and evolution. In this role, she leads scientific vision, product strategy, and commercialization efforts to bring groundbreaking biological intelligence platforms and human-AI interfaces to market.
Previously, Tawny served as Chief Revenue Officer at Paloma Health, a leading women’s health company, where she drove enterprise product commercialization, strategic growth initiatives, and national sales execution. She also held executive leadership positions at Ro, Everly Health, and J.P. Morgan, where she spearheaded business development programs, strategic FinTech projects, and complex health IT implementations. Across these roles, her innovative strategies have consistently driven revenue growth, operational efficiency, and market expansion.
Tawny holds a Bachelor of Science in Public Health from the University of Texas at Austin, a Master of Science in Individualized Genomics & Health from Johns Hopkins University, and pursued a Ph.D. in Public Health Genetics at the University of Washington.